ArticleThe Journal of experimental medicine2012

MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition.

Dai Horiuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.